RIL in Diagnostic Segment: The country’s richest man Mukesh Ambani can soon make a big bang in the diagnostic segment. His Reliance Group company Reliance Retail Ventures has prepared a plan for this. Under this plan, Reliance Retail Ventures can make a deal to buy stake in a diagnostic company in the coming days.
Table of Contents
Preparations to spend 1 to 3 thousand crores
According to a report by Business Line, Reliance Retail Ventures has prepared a plan of Rs 1000 to Rs 3000 crore to increase its presence in the diagnostic segment. This amount will be spent on buying stake in a diagnostic service provider company. Reliance Retail Ventures plans to buy majority stake in the target company.
Netmeds offers these services
Reliance Industries is already present in this segment through its subsidiary Netmeds. Netmeds has tie-ups with several diagnostic service providers such as Thyrocare, Healthians, etc. Through these partnerships, Netmeds provides pathology services to customers. Netmeds also sells various medicines online and offline.
Netmeds and Reliance deal
Reliance Industries acquired Netmeds in 2020. At that time, Mukesh Ambani’s company bought a majority stake in Netmeds for Rs 620 crore. Netmeds earlier used to work only online. After the acquisition by Reliance, Netmeds now also has an offline presence. Its first offline store was opened in January 2023. So far it has opened more than 1000 outlets across the country.
Work is going on on such a plan
Now Reliance plans to bring a diagnostic company in its portfolio which provides pathology services on its own and has its own diagnostic centers across the country. Reliance Industries is looking for such a company. Reliance Industries wants the target diagnostic company to have a good range of services offered with availability across the country. However, Reliance has not yet officially announced anything in this regard.
